BAY-588 is a glucose transporter inhibitor and derivative of BAY-876 . It selectively inhibits glucose transporter 4 (Glut4), Glut1, and Glut3 over Glut2 with IC values of 0.5, 1.18, 5.47, and >10 μM, respectively, in CHO cells expressing human recombinant transporters.